Bottom line
BBP vs RYOIX: the short answer
BBP (Virtus Biotech ETF) and RYOIX (Biotechnology Fund) are quite different portfolios: only about 15% of their top holdings (by weight) are shared.
BBP is cheaper at 0.34% vs 1.38% — a difference of $104 a year per $10,000 invested.
Over five years, BBP returned +8.4% a year vs +4.0% for RYOIX.
Updated Nov 19, 2026
BBP vs RYOIX side by side
| BBP | RYOIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Virtus | Guggenheim |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.34% | 1.38% |
| Annual cost per $10k | $34 | $138 |
| 10-yr cost on $10k (prospectus) | $431 | $1,709 |
| Max front load | None | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +32.8% | +30.7% |
| 5-yr return (annualized) | +8.4% | +4.0% |
| 10-yr return (annualized) | +10.0% | +5.9% |
| Best quarter | +28.2% | +28.3% |
| Worst quarter | −23.0% | −22.5% |
| Net assets (fund) | $98.5M | $136.8M |
| Number of holdings | 70 | 74 |
| Portfolio turnover | 29% | 75% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BBP | RYOIX | Difference |
|---|---|---|---|
| 2025 | +32.8% | +30.7% | +2.1% |
| 2024 | +3.6% | −0.7% | +4.4% |
| 2023 | +17.4% | +6.1% | +11.4% |
| 2022 | +1.0% | −13.1% | +14.0% |
| 2021 | −8.2% | +1.8% | −10.0% |
| 2020 | +22.2% | +22.1% | +0.1% |
| 2019 | +24.9% | +25.0% | −0.1% |
| 2018 | −13.8% | −9.0% | −4.8% |
| 2017 | +23.8% | +29.7% | −5.9% |
| 2016 | +6.5% | −19.5% | +26.0% |
Source: Fund prospectus bar charts
Holdings overlap
5 of BBP's top 25 holdings also appear in RYOIX's top 25.
| Holding | BBP | RYOIX |
|---|---|---|
| Regeneron Pharmaceuticals | 1.72% | 2.93% |
| Bridgebio Pharma Inc | 1.65% | 1.38% |
| Beone Medicines Ltd | 1.65% | 2.17% |
| Roivant Sciences Ltd | 1.55% | 1.66% |
| Incyte Corp | 1.52% | 1.62% |
Source: SEC Form N-PORT
BBP top 10
- Crinetics Pharmaceuticals Inc — 3.34%
- Kiniksa Pharmaceuticals International Plc — 1.97%
- Verastem Inc — 1.95%
- Precigen Inc — 1.94%
- Omeros Corp — 1.87%
- Nuvation Bio Inc — 1.77%
- Regeneron Pharmaceuticals — 1.72%
- Protagonist Therapeutics Inc — 1.71%
- Acadia Pharmaceuticals Inc — 1.69%
- Bridgebio Pharma Inc — 1.65%
RYOIX top 10
- Abbvie Inc — 8.17%
- Amgen Inc — 5.05%
- Gilead Sciences Inc — 4.49%
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
FAQ
What is the difference between BBP and RYOIX?
Which is cheaper, BBP or RYOIX?
Should I own both BBP and RYOIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.